NCT07717437招募中不适用
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 350
- 试验地点
- 31
- 主要终点
- Resectability three weeks after PVE/HVE and 5 years overall survival
研究概览
简要总结
The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clinical/imaging parameters, clinical outcomes, and safety for patients undergoing PVE/HVE.
详细描述
Retrospective and prospective
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who have undergone PVE/HVE or technical variations on this procedure
- •18 Years and older
- •Men and women
排除标准
- 未提供
结局指标
主要结局
Resectability three weeks after PVE/HVE and 5 years overall survival
时间窗: From enrolment until 5 year follow up
次要结局
- Number of complications during embolization(Perioperative)
- Clinical resection rates(Until MDT decision on resection (yes/no), approximately 3-6 weeks after the embolization)
- Kinetic Growth Rate [%/week](3 weeks after the embolization)
- Functional Growth Rate [%/week](Three weeks after the embolization)
- 90-day survival after embolization(90 days post-embolization / post-resection)
- Number of complications during surgery(Perioperative)
- 90 day survival after resection(90 days)
- Number of salvage procedures(Approximately 3-6 weeks after the embolization)
- Number of participants with disease recurrence(Until five years after the embolization/resection)
- Number of oncological interventions during follow up(Until five years after the embolization/resection)
研究者
研究点 (31)
Loading locations...
相似试验
招募中
不适用
Construction of a Portal Hypertension BiobankNCT07419724Shanghai Zhongshan Hospital1,000
尚未招募
不适用
VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)NCT07390344W.L.Gore & Associates152
招募中
不适用
A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in ChinaProgressive Familial Intrahepatic CholestasisNCT07588880Ipsen20
招募中
不适用
Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA)Portal HypertensionCirrhosisEUSNon-Cirrhotic Portal HypertensionHVPGHepatic Venous Pressure GradientNCT07424963Military University Hospital, Prague40
尚未招募
不适用
An observational study evaluating role of highly dose conformal radiotherapy in management of portal vein tumour thrombus in a case of HCCCTRI/2025/07/091458Department of Radiotherapy and Clinical Oncology, PGIMER, Chandigarh15